Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities (2016 - 2026)
Cumberland Pharmaceuticals' Cash from Investing Activities history spans 16 years, with the latest figure at -$3.1 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 11363.83% to -$3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.7 million, a 8236.82% decrease, with the full-year FY2025 number at -$4.7 million, down 8236.82% from a year prior.
- Cash from Investing Activities hit -$3.1 million in Q4 2025 for Cumberland Pharmaceuticals, down from -$690837.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for CPIX hit a ceiling of $680805.0 in Q3 2022 and a floor of -$13.5 million in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$946535.0 across 5 years, with a median of -$95940.5 in 2023.
- Biggest five-year swings in Cash from Investing Activities: soared 728.95% in 2022 and later plummeted 11363.83% in 2025.
- Tracing CPIX's Cash from Investing Activities over 5 years: stood at -$26795.0 in 2021, then plummeted by 2291.39% to -$640772.0 in 2022, then soared by 140.68% to $260639.0 in 2023, then tumbled by 110.29% to -$26809.0 in 2024, then plummeted by 11363.83% to -$3.1 million in 2025.
- Business Quant data shows Cash from Investing Activities for CPIX at -$3.1 million in Q4 2025, -$690837.0 in Q3 2025, and $285864.0 in Q2 2025.